Cannabis Lies Vol. 9: The Reform Lie

The federal move to Schedule III is a masterclass in bureaucratic maintenance. While corporations celebrate tax relief, the core structure of the drug war remains untouched. This analysis deconstructs the Reform Lie, exposing how the state uses symbolic gestures to professionalize a privilege for the few while keeping the machinery of punishment active for everyone else.

IDAHO TRIES TO STOP A VOTE BEFORE IT STARTS

Idaho lawmakers passed a resolution urging voters to reject a medical cannabis initiative before it reaches the ballot. The move highlights how officials are shaping public opinion ahead of a vote, while maintaining strict prohibition and blocking even limited access for patients.

Why Black People Still Pay More for Weed

Cannabis use rates are similar across races, but arrests are not. Black Americans are still arrested for marijuana possession at several times the rate of white Americans, even as legalization spreads. This investigation breaks down the data, the role of possession-only enforcement, and why legalization without repair keeps old lines firmly in place.

Reefer Report Card Vol. 32: Kicking the Can Again

This week’s Reefer Report Card tracks a familiar pattern in cannabis policy: delay dressed as progress. Federal lawmakers punted again on hemp regulation, states flirted with dismantling legal markets, and patients were left waiting. Oversight weakened, accountability faded, and reform stalled. Another week in weed, graded.

WHEN THE UN CAN’T STOP LEGAL WEED

As cannabis reform accelerates worldwide, the UN’s International Narcotics Control Board continues warning that decades old drug treaties still apply. This feature examines the INCB’s actual authority, the limits of treaty enforcement, and why global legalization is advancing despite institutional resistance rooted in prohibition era frameworks.

Reefer Report Card Vol. 30: The Floor Starts to Give

Reefer Report Card Vol. 30 tracks a week where legalization stalled while rollback efforts gained ground. Ballot initiatives threatened regulated markets, federal reform stayed stalled, and patients were left navigating uncertainty. Demand remained strong, but oversight weakened. Another week where cannabis survived while governance quietly failed.

Create a website or blog at WordPress.com

Up ↑